Article
Advancing CRISPR-Based Programmable Platforms beyond Genome Editing in Mammalian Cells.
ACS synthetic biology - 20 Dec 2019
Higashikuni Yasutomi, Lu Timothy K
Abstract excerpt
Human diseases are caused by dysregulation of cellular biological programs that are encoded in DNA. Unveiling the endogenous programs and encoding new programs into the genome are key to creating novel diagnostic and therapeutic strategies. CRISPR/Cas9, originally identified in bacteria, has revolutionized genome editing in mammalian cells. Recent advances in CRISPR technologies have provided new programmable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
